UK markets closed

Moderna, Inc. (0A45.IL)

IOB - IOB Delayed price. Currency in USD
Add to watchlist
171.13-5.07 (-2.88%)
At close: 07:14PM GMT
Full screen
Previous close176.20
Bid166.86 x N/A
Ask175.40 x N/A
Day's range169.05 - 174.40
52-week range115.30 - 345.20
Avg. volume17,325
Market cap65.972B
Beta (5Y monthly)1.73
PE ratio (TTM)6.16
EPS (TTM)27.80
Earnings date22 Feb 2023 - 27 Feb 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why

    Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.

  • Motley Fool

    The Worst Mistake Moderna Investors Can Make in 2023

    Moderna (NASDAQ: MRNA) investors didn't need to have too much patience in the early days of the pandemic. The company brought its coronavirus vaccine candidate from drawing board to market in about nine months. Next year, though, Moderna investors may need to rely on their patience.

  • Motley Fool

    Novavax Stock: Buy, Sell, or Hold in 2023?

    In the early days of the pandemic, investors bet Novavax (NASDAQ: NVAX) would be a coronavirus vaccine winner. When the biotech's vaccine candidate fell behind, though, investors lost faith. With its shares down almost 90% this year, you may be wondering if Novavax presents a great buying opportunity.